Press releases / news
On August 28, Hemcheck was conditionally approved for continued listing on Nasdaq. After that, a lot of work has been done to implement all the steps necessary to complete the transaction with Bio Vit ...
Read more
Hemcheck has been approved for continued listing by Nasdaq, subject to the transaction with Bio Vitos being completed and other customary conditions such as updating the website after the transaction ...
Read more
Hemcheck has received a first smaller order from Astemed, which is the company's distributor in the United Arab Emirates. The order concerns instruments and v-Test and is of minor economic value.
- ...
Read more
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth over 10,000 ...
Read more
Hemcheck has received a first small order from the university hospital Charité in Berlin. Charité is one of the largest university hospitals in Europe with a budget of approximately EUR 2.3 billion. ...
Read more
Hemcheck and Biovitos have signed an additional agreement which enables Hemcheck to send out a calling to the extra general shareholders meeting that will decide on the deal, one week later than what ...
Read more
Hemcheck has received a first follow-up order from its Finnish distributor, Vingmed, which is also Hemcheck's distributor in Sweden and Norway. The order concerns s-Test and bgs-Test and is of minor e ...
Read more
Hemcheck has received another follow-up order from its UK distributor, CLS. The order concerns instruments for diagnostic use and bgs-Test and is of lower economic value.
- We have a good trend wit ...
Read more
Hemcheck Sweden AB has received a follow-up order from AREVA in the US. The order is a follow-up order after a first successful evaluation phase and is for research use. AREVA is a research program of ...
Read more
As previously communicated, if the conditional deal with Bio Vitos Medical Limited is approved, Hemcheck acquires IP rights regarding the use of iron succinate for the treatment of patients diagnosed ...
Read more
Hemcheck has received a follow-up order from its French distributor, Eurobio Scientific, corresponding to approximately SEK 80,000. The order concerns instruments for diagnostic use.
- We have a po ...
Read more
Hemcheck has received a follow-up order from its UK distributor, CLS. The order concerns instruments for diagnostic use and bgs-Tests and is of smaller economic value.
- Orders continue to come in, ...
Read more
Hemcheck has received a first order from Landspitali, the leading university hospital in Iceland. The order is a first test order regarding both v-Test and bgs-Test and is of lower economic value.
...
Read more
Hemcheck has received a follow-up order from its Spanish distributor, SDO Medical. The order concerns instruments for diagnostic use and is of minor economic value.
- It is very positive that we ha ...
Read more
Hemcheck has received another follow-up order from its Irish distributor, Cruinn Diagnostics (“Cruinn”). The order concerns one-time tests for both vacuum tubes and syringes.
- We continue to r ...
Read more
Hemcheck has extended the agreement with Laboratory Medicine within Region Skåne, Sweden. The extension involves minor revenues for Hemcheck and is related to the same project as previously communica ...
Read more
Hemcheck has received another follow-up order from its Irish distributor, Cruinn Diagnostics (“Cruinn”). The order concerns instruments for diagnostic use and is linked to a university hospital th ...
Read more
Hemcheck has received an important order from a major OEM worth over SEK 120,000. The order concerns several systems for hemolysis detection and single-use tests for diagnostic use and is carried out ...
Read more
Hemcheck has received an important follow-up order from Deutsches Herzzentrum Berlin worth approximately SEK 150,000. The order concerns several systems for hemolysis detection for diagnostic use and ...
Read more
Hemcheck Sweden AB has received an additional follow-up order from its Greek distributor Antisel. The order is of lower economic value, but shows again that Antisel is active in the market and that Gr ...
Read more
Hemcheck Sweden AB has received a small follow-up order from Levi Biotech, its Italian distributor. The order is in addition to the initial order already placed in connection with the signing of the a ...
Read more
Hemcheck Sweden AB has signed a distributor agreement with Levi Biotech regarding the Italian market. The agreement is for 3 years and entails a first order during the fourth quarter, like previous si ...
Read more
Hemcheck Sweden AB has received a small follow-up order from Promedica, a Czech distributor. The order concerns bgs-Test and v-Test.
- It is clearly positive that we have received this follow-up or ...
Read more
Hemcheck Sweden AB has today received a follow-up order from Tartu University Hospital in Estonia. The hospital already uses Hemcheck's products on an ongoing basis and this order means an increase in ...
Read more
Hemcheck Sweden AB has today received a follow-up order from its British distributor CLS. The order is of smaller size but shows that CLS is active in the market and that British customers are in dema ...
Read more
2022-11-01
Hemcheck Sweden AB has received an order from UKR, the university hospital in Regensburg. The order is a small first order regarding bgs-Test and refers to diagnostic use. The University Hospital in R ...
Read more
Hemcheck Sweden AB has received an order from the AREVA research program in the US. The order is a first order, is of minor economical value and is intended for research use. AREVA is a research progr ...
Read more
2022-09-05
Hemcheck Sweden AB has today received a first follow-up order from its Greek distributor Antisel. The order is of lower economic value but shows that Antisel is active in the market and that Greek cus ...
Read more
Hemcheck Sweden AB has today received an additional order from its French distributor Eurobio Scientific. The order is of lower economic value but the third in a relatively short time and includes all ...
Read more
Hemcheck Sweden AB has signed a distributor agreement with SDO Medical regarding the Spanish market. The agreement entails an initial evaluation period of 6 months and a requirement for a first order. ...
Read more
Hemcheck Sweden AB has received an extended order of EUR 11,000 from its French distributor Eurobio Scientific. The order is the single largest to date from a distributor and includes all types of tes ...
Read more
Hemcheck Sweden AB has received an evaluation order from Levi Biotech, an Italian distributor. The order is of lower economic value but shows the interest that exists in the Italian market, and it is ...
Read more
Hemcheck, together with the Hospital de la Santa Creu in Sant Pau, has completed an evaluation of the compatibility between the v-Test and the S-Monovette blood sampling system. The results are very g ...
Read more
2022-06-20
Hemcheck has received an order from a medical technology company based in France that focuses on technology supported blood sampling. The order is of lower economic value but shows the potential in re ...
Read more
2022-06-08
Hemcheck will participate in the BioStock Life Science Spring Summit on June 9, as one of about 30 life science companies.
The presentation starts at 13:40 on June 9, and the event can be followed ...
Read more
Hemcheck has received a first evaluation order from Deutsches Herzzentrum Berlin. The order is of lower financial value, but there is an opportunity for additional follow up orders. The order refers t ...
Read more
Hemcheck has signed an agreement with Laboratory Medicine in Region Skåne, Sweden. The agreement involves minor revenues for Hemcheck and is for a project where Hemcheck's v-Test with equipment confi ...
Read more
Hemcheck has received a follow-up order from Kuressaare Hospital in Estonia, regarding hemolysis detection in connection with blood gas analysis. The order is for bgs-Test and is of lower economic val ...
Read more
Hemcheck has received a first follow-up order from its Irish distributor, Cruinn Diagnostics ("Cruinn"). The order regarding bgs-Test, is of lower economic value, but is linked to a university hospita ...
Read more
After an efficient process, Hemcheck has CE-marked its products for diagnostic purposes. This strengthens the sales and profitability potential as it enables sales to new segments and at clearly highe ...
Read more
2022-05-12
Hemcheck has received a first order from Kuressaare hospital in Estonia. The order is of lower economic value however there is potential for additional follow up orders. This will be Hemcheck's third ...
Read more
2022-04-28
Hemcheck Sweden AB has signed a distributor agreement with Beamed Trading (“Beamed”) regarding the Jordanian and Qatari markets. The agreement entails an initial order like previous similar agreem ...
Read more
Hemcheck Sweden AB has signed a distributor agreement with Vingmed, one of the largest distributors in the Nordic region. The agreement entails an initial order like previous similar agreements.
- ...
Read more
Hemcheck has received a first evaluation order from Sahlgrenska University Hospital. The order is of smaller economic value but is potentially important as Sahlgrenska is one of the larger hospitals i ...
Read more
After Hemcheck received good feedback from the study at Liverpool Heart and Chest Hospital, as well as receiving good indications from other user tests, the company has decided to evaluate the possibi ...
Read more
Hemcheck Sweden AB has signed a three-year distribution agreement with Eurobio Scientific, a leading distributor and manufacturer of medical equipment based in France, with operations across several o ...
Read more
Hemcheck has received positive feedback from the trial at the Liverpool Heart and Chest Hospital, which was designed to assess the potential clinical use of Hemcheck’s products related to cardiac su ...
Read more
Hemcheck has received a first order from Narva hospital in Estonia. The order is of lower economic value however there is potential for additional follow up orders. This will be Hemcheck's second cust ...
Read more
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth ca 100,000 ...
Read more
2022-02-08
Hemcheck’s new product for the blood gas market is now CE marked. The bgs-Test is a hemolysis test which can receive a significantly larger amount of blood volume compared to current tests, fully fu ...
Read more
Hemcheck Sweden AB has received a so-called "Intention to Grant" from the European Patent Office, "EPO", regarding the patent application for its filter solution. This means that the EPO intends to ap ...
Read more
University Hospital Centre Zagreb have successfully finalized two evaluation studies of Hemcheck’s products at the Department of Laboratory Diagnostics. These formal evaluations preliminary results ...
Read more
2021-11-02
Hemcheck Sweden AB has received an evaluation order from the International Agency for Research on Cancer (IARC) regarding reader and disposable tests (s-Test). The order is of minor economical value a ...
Read more
Hemcheck Sweden AB has signed a 3-month evaluation agreement with potential continuation into a 36-month long distribution agreement with Sanova Pharma GesmbH (”Sanova”), regarding the Austrian ma ...
Read more
Hemcheck Sweden AB has signed an exclusive distribution agreement with Cambridge Life Sciences Ltd (“CLS”), a leading manufacturer and distributor of assays, laboratory and medical equipment in th ...
Read more
Abstract based on Hemcheck’s studies at Sant Pau, Barcelona, selected for presentation at EuroMedLab
2021-10-07
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth ca 100,000 ...
Read more
An article has been published in the Journal of Laboratory Medicine highlighting the importance of hemolysis detection in blood gas analysis as well that Hemcheck has a solution for this issue. Author ...
Read more
2021-08-13
Hemcheck Sweden AB has received an evaluation order from a British distributor. The order is of minor economic value but validates the interest that exist in the British market.
-We have several di ...
Read more
Hemcheck Sweden AB and Hemakim Tibbi Ürünler San.Ve Tic. A.S (”Hemakim”) has agreed to continue the collaboration into a distribution agreement regarding the Turkish market valid until the end o ...
Read more
2021-07-01
Hemcheck Sweden AB has signed an exclusive distribution agreement with PT Setia Guna Medika, a leading distributor of laboratory and medical equipment in Indonesia. The agreement is valid until the en ...
Read more
Hemcheck is starting a collaboration with Liverpool Heart and Chest Hospital to assess the potential clinical use of Hemcheck’s products related to cardiac surgeries performed at the hospital. The e ...
Read more
2021-06-01
Hemcheck Sweden AB has signed an exclusive distribution agreement with Cruinn Diagnostics, a leading distributor of laboratory and medical equipment in Ireland. The agreement will be in force from Jul ...
Read more
Hemcheck Sweden AB has established an international clinical advisory board. The board will act as advisors to the company with regards to the continued work of building clinical evidence, evaluation ...
Read more
Hemcheck Sweden AB has filed a new patent application regarding a product system for the blood gas market. This is according to the current strategy to protect the company’s intellectual property. T ...
Read more
Hemcheck Sweden AB and Hospital de la Santa Creu i Sant Pau have successfully finalized two studies at the ICU and the Biochemistry department.
The first in the ICU was set up to evaluate the frequ ...
Read more
2021-04-19
Hemcheck Sweden AB has signed an exclusive distribution agreement with Abdulla Fouad for Medical Supplies and Services Company (“AFMS”), a leading distributor of laboratory and medical equipment i ...
Read more
2021-03-31
Hemcheck Sweden AB has signed a 3-month evaluation agreement, starting in March 2021, with potential continuation into a 24-month long distribution agreement with Medtech Corporation Trading (”Medte ...
Read more
Hemcheck Sweden AB has received a preliminary approval, a so-called Notice of Allowance, from the USPTO regarding Hemcheck’s design right application for its reader. When this application is finally ...
Read more
Hemcheck Sweden AB has signed an exclusive distribution agreement with Advanced Technology Company K.S.C.P. (“ATC”), one of the leading distributors of medical equipment in Kuwait. The agreement w ...
Read more
2021-01-19
The board of Hemcheck Sweden AB (publ) ("Hemcheck" or "The Company") has, through the authorization given by the extra general meeting held on December 15th 2020, and according to what The Company ind ...
Read more
Hemcheck Sweden AB has signed an agreement with Capio S:t Göran’s hospital regarding delivery of readers and one-time disposables (v-Test) for usage at the emergency department. After the successfu ...
Read more
Hemcheck Sweden AB has gotten its patent application regarding the filter solution to receive and separate plasma from whole blood approved by the USPTO.
–It’s very positive that we have gotten ...
Read more
Hemcheck Sweden AB has received a follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth 9700 Euro.
...
Read more
Hemcheck Sweden AB has signed a subscription agreement with Tartu university hospital regarding delivery of readers and one-time disposables (v-Test) for usage at the hematology and oncology clinic. T ...
Read more
Hemcheck Sweden AB has extended the evaluation agreement with Hemakim Tibbi Ürünler San.Ve Tic. A.S (”Hemakim”) to the end of 2020. The evaluation agreement that is now extended was formed to ev ...
Read more
The UK National Institute for Health and Care Excellence (NICE) has issued a Medtech Innovation Briefing (MIB) on Hemcheck’s novel point of care hemolysis detection technology. The briefing reports ...
Read more
Hemcheck has concluded the prepatory phase of the Bridgehead Europe program by selecting two focus markets and two local partners to support Hemcheck in the internationalization process. For the Nethe ...
Read more
Hemcheck Sweden AB and Foundation for Innovative New Diagnostics (FIND) have signed an agreement regarding delivery of reader and one-time tests (v-Test). The order is a first evaluation order and is ...
Read more
Hemcheck Sweden AB has filed a patent application regarding a new product for the blood gas market. This is according to the current strategy to protect the company’s intellectual property. Developm ...
Read more
Hemcheck Sweden AB has been selected by a jury to participate in the EIT Health Bridgehead Europe program. The EIT, European Institute for Innovation and Technology, is set up by the European Union ...
Read more
Hemcheck Sweden AB has signed a 3-month evaluation agreement, starting in June 2020, with potential continuation into a 33-month long distribution agreement with Hemakim Tibbi Ürünler San.Ve Tic. A. ...
Read more
Hemcheck Sweden AB has signed a subscription agreement with SYNLAB Sverige AB regarding delivery of one reader and one-time tests (v-Test) for usage within training and occupational health services.
...
Read more
Hemcheck Sweden AB has signed a 26-month long distribution agreement with Antisel Selidis Bros SA (”ANTISEL”), one of the leading distributors of medical equipment in Greece and Cyprus. The agreem ...
Read more
2020-04-01
2020-02-14
PRESS RELEASE
Hemcheck Sweden AB and Capio S:t Göran’s hospital have, as earlier communicated, finalised the study at the emergency care unit, to evaluate if Hemcheck’s product concept can low ...
Read more
2020-01-21
PRESS RELEASE
Hemcheck Sweden AB and Capio S:t Göran’s hospital have finalised the study at the emergency care unit, to evaluate if Hemcheck's product concept can lower the hemolysis rate in hem ...
Read more
PRESS RELEASE
Hemcheck Sweden AB and Siemens Healthcare A/S (Siemens Healthineers) have entered into a collaboration agreement focused on the blood gas market in the Nordics. The agreement is set f ...
Read more
Hemcheck Sweden AB has today submitted all required documentation to the Swedish Medical Products Agency, to extend the CE mark regarding hemolysis tests in vacuum tubes, the v-Test, to include so-cal ...
Read more
Hemcheck Sweden AB and Capio S:t Göran's Hospital have received approval from the Swedish Ethical Review Authority (EPN) to perform a study at Capio S:t Göran's hospital emergency care unit to evalu ...
Read more
A recent clinical study published in the Scandinavian Journal of Clinical and Laboratory Investigation, shows that hemolysis is frequently present in blood gas samples at emergency departments ...
Read more
2019-05-19
Hemcheck’s hemolysis detection test for vacuum tubes, the most common type of blood sample collector in healthcare, has obtained a CE-mark. The CE-mark is a certification of compliance to health and ...
Read more
Hemcheck’s hemolysis detection test for blood gas syringes has obtained a CE-mark. The CE-mark is a certification of compliance to health and safety standards that must be obtained before the produc ...
Read more
Are you the one we are looking for? We will now strengthen our team with a Quality Assurance Manager
2018-05-18
Photo Rikard Ekberg
Since 2016 Anna Dalgaard has been a Member of the Board of Directors in HemCheck – last Monday she was elected chairman.
– HemCheck is at an exciting stage, and I look for ...
Read more
2018-01-23
HemCheck has signed a long-term agreement with SHL Technologies Limited, a subsidiary of the international SHL Group. The agreement entails SHL will manufacture the disposable tests that are used in H ...
Read more
Karlstad November 20, 2017 – The medical technology company HemCheck, which is developing a point of care test for hemolysis detection, can today announce that the digital reader in its product conc ...
Read more
New project, new collaboration, and a new opportunity to make a difference. In partnership with a researcher from Karolinska Institutet, HemCheck will investigate the incidence of hemolysis in blood g ...
Read more
Read more >> (Only in Swedish) ...
Read more
2017-10-10
2017-10-04
2017-09-20
2017-09-08
HemCheck has an exhibit at the LINUS days in Visby, and we have already had many fruitful conversations with biomedical analysts from all over Sweden. We are inspired by their creative ideas regarding ...
Read more
hemCheck, a medical technology company addressing the issue of hemolysis, announces results from user tests at Karlstad Central Hospital, where nurses used a prototype of hemCheck’s point of care te ...
Read more
2017-05-04
hemCheck Publishes the Annual Report for 2016 - Regulatory
This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Switzer ...
Read more
NOTICE OF ANNUAL GENERAL MEETING, HEMCHECK SWEDEN AB (PUBL) - Regulatory
This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong K ...
Read more
Improving quality in the preanalytical phase through innovation is not only the slogan for the 4th EFLM-BD European Conference on Preanalytical Phase in Amsterdam, it is also the groundwork and corner ...
Read more
hemCheck approved for trading on Nasdaq First North - Regulatory
This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Swi ...
Read more
A global problem and its potential solution is presented in this short film.
...
Read more
On Tuesday the 10th of January Annelie Brolinson, the CEO of hemCheck, will be on stage at Handelskammaren Värmlands regular and, as always, sold out breakfast seminar in Karlstad.
-This will be the ...
Read more
